Fhit protein expression in hereditary and sporadic colorectal cancers

Polish Journal of Pathology

Volumn 52, Issue 3, 2001, Pages 125-132

  Hadaczek, P ^a   Debniak T ^a   Kurzawski, G ^a   Jakubowska, A ^a   Huzarski, T ^a   Huebner, K ^a   Lubinski J ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; PROTEIN EXPRESSION;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 0034750499     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden
2. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients
3. Germline mutation of the hMSH6/GTBP gene in an atypical HNPCC kindred
4. Loss of FHIT expression in gastric carcinoma
5. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: Implications for the mechanism of fragile site induction
6. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer
7. Fhitness and cancer
8. FHIT gene therapy prevents tumor development in Fhit-deficient mice
9. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors
10. Loss of Fhit expression in renal neoplasias: Correlation with histogenic class
11. Absence or reduction of Fhit expression in most clear cell renal carcinomas
12. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions
13. Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability
14. Genomic FHIT analysis in RER+ and RER- adenocarcinoma of the pancreas
15. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
16. Reduced Fhit expression in familial and sporadic breast carcinomas
17. Effect of adenoviral transduction of FHIT into esophageal cancer cells
18. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression
19. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines
20. Structure of the human MLH1 locus and analysis of large hereditary nonpolyposis colorectal carcinoma kindred for MLH1 mutations
21. DNA isolation by rapid method from human blood samples: Effects of MgC12, EDTA, storage time, and temperature on DNA yield and quality
22. Fragile sites in human chromosomes as regions of late replicating DNA
23. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
24. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients
25. HNPCC associated with germline mutation in the TGF-B type II receptor gene
26. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas
27. Genetic susceptibility to non-polyposis colorectal cancer
28. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer
29. The FHIT gene at 3p14.2 is abnormal in breast carcinomas
30. Mutations of two PMS homologues in HNPCC
31. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
32. Mutation of a mutL homolog in hereditary colon cancer
33. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma
34. Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21
35. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities
36. The FHIT gene at 3p14.2 is abnormal in lung cancer
37. Evaluation of the FHIT gene in colorectal cancers
38. Dinucleotide repeat polymorphism at the D18S35 locus
39. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis